Table of Contents
| << Previous Issue | Mar 2009 (Vol: 2009, Issue: 3) | Next Issue >> |
- Section: Editorial
-
Biosimilars – a risky bet?
- Section: Features
-
Nycomed Looking for Buyers
-
Is Allergan the Next Takeover Target?
-
Elan’s Shares Rise on Takeover Speculation
- Section: Licensing
-
Pfizer Looks for Growth in Generics and Eyecare
-
Lilly Looks to NeuroSearch to Fill Pipeline Gap
-
Merck Serono and Fast Forward to Speed Multiple Sclerosis Developments
- Section: Mergers & Acquisitions
-
Merck to Merge with Schering-Plough in a US$41.1 B deal
-
Roche Gets Genentech for US$46.8 B
-
Could J&J Trip up the Merck and Schering-Plough Deal?
-
Gilead Rescues CV Therapeutics
- Section: Research & Development
-
Zydus Cadila and Lilly Enter US$300 M Research Pact
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS